Learn more about whether BioMarin Pharmaceutical Inc. or Kymera Therapeutics, Inc. is a better investment based on AAII's A+ ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including ANI ...

Healthcare may not lead the next market rally, but current levels offer compelling risk/reward for contrarian investors ...

Pfizer's deal with the U.S. government, a robust pipeline, and a reasonable valuation make it a compelling buy. There are several compelling reasons to invest in pharmaceutical companies, especially ...

Rigel Pharmaceuticals saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 91 the day before.

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

As of Friday, November 07, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 13.64%, which has investors ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Ipca Laboratories is showing signs of a bullish reversal with a rounding bottom pattern forming on daily charts, suggesting ...